Studies related to Lung Function and Pelargonium sidoides

Pelargonium Sidoides Preparation (EPs 7630) In The Treatment Of Acute Bronchitis In Adults And Children

Effect Increase
Trial Design Double blind
Trial Length 1-2 Weeks
Number of Subjects 2023
Sex Both Genders
Age Range 0-1, 1-6, 7-12, 13-17, 18-29, 30-44, 45-64, 65+
Notes for this study:
Two weeks supplementation of EPs7630 to persons of all ages (30 drops thrice daily for adults, but 20 drops thrice daily for those between 6-12 and 10 drops thrice daily for those younger than 6) was able to significantly reduce overall symptoms as assessed by the BSS by around 86% with 68% of the sample reporting more than a 5 point reduction.

Most other comorbidities such as fever, fatigue, and headache were reduced in the range of 80-94.6%. Rhonchi (93.1% remission) chest pain during cough (94.1%), and shortness of breath (93.2%), but cough was only abolished in 56.2% of persons.

Full details on all 10 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.